๐”– Scriptorium
โœฆ   LIBER   โœฆ

๐Ÿ“

Generic Drug Product Development: Bioequivalence Issues

โœ Scribed by Isadore Kanfer (Author); Leon Shargel (Author)


Publisher
CRC Press
Year
2007
Leaves
287
Edition
1
Category
Library

โฌ‡  Acquire This Volume

No coin nor oath required. For personal study only.

โœฆ Synopsis


The assessment of bioequivalence is an important process whereby the bioavailability of a generic drug product is compared with its brand-name counterpart. Generic pharmaceutical products must be approved as therapeutic equivalents to the brand name alternative in order to be interchangeable. The demonstration of bioequivalence is an important comp

โœฆ Table of Contents


Introduction - Bioequivalence Issues. Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book). Pharmaceutical Alternatives: Considerations for Generic Substitution. Pharmacodynamic Measurements for Determination of Bioequivalence. Bioequivalence Using Clinical Endpoint Studies. Evaluation of Bioequivalence of Highly-Variable Drug Products. Statistical Considerations: Alternate Designs And Approaches For Bioequivalence Assessments. Population Pharmacokinetic Approaches for Assessing Bioequivalence. Role of Metabolites in Bioequivalence Assessment. Implications of Chirality for the Assessment of Bioequivalence. Effect of Food on Bioavailability and the Assessment of Bioequivalence. Bioequivalence Assessment of Endogenous Drug Substances : Pharmacokinetics and Statistical Evaluation.

โœฆ Subjects


Bioscience;Pharmaceutical Science;Drug Design & Development;Pharmaceutical Science Regulatory;Engineering & Technology;Manufacturing Engineering;Pharmaceutical Manufacturing


๐Ÿ“œ SIMILAR VOLUMES


Generic Drug Product Development: Bioequ
โœ Isadore Kanfer (ed.), Leon Shargel (ed.) ๐Ÿ“‚ Library ๐Ÿ“… 2008 ๐Ÿ› Informa Healthcare ๐ŸŒ English

The assessment of bioequivalence is an important process whereby the bioavailability of a generic drug product is compared with its brand-name counterpart. Generic pharmaceutical products must be approved as therapeutic equivalents to the brand name alternative in order to be interchangeable. The de

Generic Drug Product Development: Intern
โœ Isadore Kanfer (ed.), Leon Shargel (ed.) ๐Ÿ“‚ Library ๐Ÿ“… 2010 ๐Ÿ› Informa Healthcare ๐ŸŒ English

Due to a worldwide need for lower cost drug therapy, use of generic and multi-source drug products have been increasing. To meet international patent and trade agreements, the development and sale of these products must conform to national and international laws, and generic products must prove that

Bioequivalence Studies in Drug Developme
โœ Dieter Hauschke, Volker Steinijans, Iris Pigeot(auth.) ๐Ÿ“‚ Library ๐Ÿ“… 2007 ๐ŸŒ English

Studies in bioequivalence are the commonly accepted method to demonstrate therapeutic equivalence between two medicinal products. Savings in time and cost are substantial when using bioequivalence as an established surrogate marker of therapeutic equivalence. For this reason the design, performance

Generic Drug Product Development: Solid
โœ Leon Shargel ๐Ÿ“‚ Library ๐Ÿ“… 2004 ๐Ÿ› CRC Press ๐ŸŒ English

Focusing on immediate-release and modified-release dosage forms, the book collects in-depth discussions from more than 30 noted specialists on topics such as quality control, experimental formulation, pharmaceutical ingredients, and bioequivalence, and considers key elements in the formulation of ge

Generics and Bioequivalence
โœ Andre J. Jackson (Editor) ๐Ÿ“‚ Library ๐Ÿ“… 1994 ๐Ÿ› CRC Press

<p>Published in 1994: This text focuses on the determination of bioequivalence between formulations that are pharmaceutically equivalent and manufactured using acceptable chemistry, manufacturing and controls and in accordance with Good Manufacturing Practices.</p>

Development of Generic Drug Products: So
โœ Shargel L. (Ed), Kanfer I. ๐Ÿ“‚ Library ๐Ÿ“… 2004 ๐ŸŒ English

Keeping pace with the latest technologies in the field, this guide describes the development of solid oral generic drug products from project initiation to market approval. Focusing on immediate-release and modified-release dosage forms, the book collects in-depth discussions from more than 30 noted